Health Open for ApplicationsPAR-25-184

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health opportunity PAR-25-184

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthPAR-25-184Grants.gov

Related Grants

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Application Deadline

15 October 2027

343 days remaining

Opens: 26 Nov 2024

Programme Details

Programme Code

PAR-25-184